Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:e89
Published online before print March 27, 2008, doi: 10.1161/STROKEAHA.108.515635
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/5/e89    most recent
STROKEAHA.108.515635v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dawson, J.
Right arrow Articles by Walters, M. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dawson, J.
Right arrow Articles by Walters, M. R.

(Stroke. 2008;39:e89.)
© 2008 American Heart Association, Inc.


Letters to the Editor

Response to Letter by Proctor

Jesse Dawson, MRCP; Terence J. Quinn, MRCP Matthew R. Walters, MD

Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK

Response:

Dr Proctor1 raises several important issues which concur with Amoro and colleagues’ conclusion2 that the potential benefits of elevated serum uric acid are independent of the likely relationship between chronically elevated serum uric acid and cardiovascular disease. Thanks to Amoro et al, there is now data from both the basic science and clinical research arenas to suggest that infusion of uric acid after stroke could reduce free radical–mediated injury, a potential treatment for an area sorely in need of an advance. However, as discussed, data exist to support uric acid reduction as a preventative strategy in those at risk of atherosclerotic disease.

It seems unlikely, however plausible, that explanations for a circumstantial beneficial or detrimental effect of uric acid may be that these differences will not lead to confusion in wider nonspecialist circles. Such confusion could ultimately hinder adoption of these strategies in either research or clinical circles—"you want me to administer uric acid, but I thought uric acid was bad for you?" As such, we welcome the attention given to this area in recent issues of Stroke.

Proctor also highlights evidence suggesting that uric acid itself may mediate oxidative stress–related damage, rather than this being a consequence of its mechanism of generation (xanthine oxidase activity). Again, there is evidence for (some of which he highlights) and against this hypothesis. A series of elegant studies by Struthers et al3 suggest that the beneficial effects of allopurinol on a variety of measures of endothelial function relate to a reduction in xanthine oxidase activity, and not uric acid reduction while other data suggest uric acid reduction is important.4 Clearly, more studies are needed to disentangle causal mechanisms so we can better direct evaluation of potential therapies.

Acknowledgments

Disclosures

None.

References

1. Proctor PH. Uric acid: neuroprotective or neurotoxic. Stroke. 2008; 39: e88.[Free Full Text]

2. Chamorro A, Planas AM. Yin and yang of uric acid in patients with stroke. Response. Stroke. 2004; 35: e11–e12.[CrossRef][Medline] [Order article via Infotrieve]

3. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006; 114: 2508–2516.[Abstract/Free Full Text]

4. Høiggen A, Alderman M, Kjeldsen SE, Julius S, Devereux RB, De Faire U, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney International. 2004; 65: 1041–1049.[CrossRef][Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
StrokeHome page
P. H. Proctor
Uric Acid and Neuroprotection
Stroke, August 1, 2008; 39(8): e126 - e126.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/5/e89    most recent
STROKEAHA.108.515635v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dawson, J.
Right arrow Articles by Walters, M. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dawson, J.
Right arrow Articles by Walters, M. R.